Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia (2022)
Attributed to:
Data science and pharmacoepidemiology for outcome improvement in severe mental illness (DS-SMI)
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2022.24163
PubMed Identifier: 35900760
Publication URI: http://europepmc.org/abstract/MED/35900760
Type: Journal Article/Review
Parent Publication: JAMA Network Open
Issue: 7
ISSN: 2574-3805